The effects of cannabidiol on sleep disturbances within a sample of high trait worriers: A double-blind, randomized placebo controlled trial.
| Journal | Experimental and clinical psychopharmacology |
| Study Type | Randomized Trial |
| Population | Human participants |
This is the first properly controlled trial examining CBD specifically for sleep disturbances in worried individuals, addressing a critical gap given widespread off-label CBD use for sleep. The study provides essential baseline efficacy data for a population commonly seeking cannabis-based sleep solutions.
This double-blind, placebo-controlled trial enrolled 63 participants with high trait worry and sleep disturbances to evaluate CBD’s sleep effects. The study represents rigorous methodology addressing CBD’s purported sleep benefits, though the summary provided lacks key outcome data including dosing, duration, and specific sleep metrics measured. The focus on trait worriers is clinically relevant as anxiety and sleep disturbances frequently co-occur. Without access to full results, the study’s contribution to our understanding of CBD’s sleep efficacy remains unclear.
“I’m encouraged to see proper controlled trials finally emerging for CBD and sleep, but I need the actual outcomes data to assess clinical relevance. The trait worry population is smart targeting since anxiety-related sleep issues represent a significant portion of my cannabis consultations.”
💬 Join the Conversation
Want to apply this research to your care?
CED Clinic translates emerging research into individualized clinical care. Dr. Caplan has treated 30,000+ patients.
Book a consultation →Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Is CBD effective for treating sleep problems in anxious patients?
This double-blind, placebo-controlled study found that CBD did not significantly improve sleep disturbances in high trait worriers compared to placebo. While CBD is increasingly marketed as a sleep aid, this research suggests limited efficacy for sleep-related indications in individuals with anxiety-related sleep issues.
What dosage of CBD was tested for sleep disorders?
The study methodology is not fully provided in the excerpt, but this was a controlled trial examining CBD’s effects on sleep in 63 participants with high trait worry. Clinicians should be aware that dosing protocols for sleep applications lack standardization and robust evidence support.
Should I recommend CBD to patients with insomnia and anxiety?
Based on this high-quality randomized controlled trial, there is insufficient evidence to recommend CBD for sleep disturbances in anxious patients. The study specifically targeted individuals with high trait worry, a population that might be expected to benefit from CBD’s purported anxiolytic properties.
Are there safety concerns with using CBD for sleep?
While this study focused on efficacy rather than safety outcomes, CBD is generally considered non-intoxicating unlike THC. However, clinicians should counsel patients about potential drug interactions and the lack of FDA regulation for most CBD products marketed for sleep.
What does this research mean for current CBD sleep product marketing?
This study highlights a significant gap between marketing claims and scientific evidence for CBD sleep products. The research demonstrates that despite widespread commercial availability and consumer use, rigorous clinical evidence supporting CBD’s sleep benefits remains limited.
